MSHP 2011 Annual Conference
March 24-25, 2011
Duluth Entertainment Convention Center
“Evolution of Pharmacy Practice with a Futuristic Vision”
Agenda/Speakers/CE Hours/ACPE Numbers/Objectives
Thursday, March 24th
Time
Total
Hours
8:15 – 9:15
1 hr
Speaker/Presentation Title
Richard Schooley, Poet, Storyteller and Strategist - “The Fierceness of Changing
Landscape”
0134-0000-11-032-L04-P; 0134-0000-11-032-L04-T
Program Learning Objectives:
1. When something new breaks into the world, whether in the world of work or
our personal lives, it is by the very nature of its newness, unknown. Many fear
the unknown. Others approach it with a curiosity. The first learning objective
is to stay in the question. Known by scientists, artists and explorers, questions
propel us from the unknown to the known.
2. Change is disorienting. In the area of practice change, one must extinguish old
behavior in favor of new. When that change involves others beyond oneself,
the order of magnitude is far greater. As complications —seen and unseen,
anticipated and unanticipated — collide, one can lose perspective. Maintaining
perspective during periods of intense change is the second learning objective.
Stopping to understand the story you’re in is the unexpected compass.
3. While implementing significant professional change, individuals undergo a
change themselves. The third learning objective is to instill an ethos of
personal mastery when implementing something new. Practice is the key to
mastery and self mastery has practices of its own.
4. Resistance is a natural aspect of any change cycle. People, in particular, and
systems prefer to perpetuate the known. One critical component to
transforming resistance into action is a shared, compelling vision. But vision is
not a static idea; in fact, it is highly dynamic, requiring constant and mutual
understanding by all involved. Achieving mutual understanding is the fourth
learning objective.
5. Leading others through changing landscape is among the most professionally
challenging acts of any pharmacist or technician. It requires a continuous
sense of course and direction, an intimate knowledge of the terrain ahead and
the ability to encourage forward progress by others. The fifth learning
objective is learning to lead in-between — in-between the old and the new.
That is where leadership takes place.
6. Strategy is a straightforward idea, even if difficult to conceive and execute.
Failing to maintain an esprit de corps is perhaps the most often overlooked
strategic element in any change process, despite the overwhelming human
component to change. Because humans are the greatest conundrum of any
change effort, learning to inspire others is the sixth keynote objective.
In brief:
1. Staying in the question
2. Maintaining perspective
3. Instilling an ethos of personal mastery
4. Achieving mutual understanding
5. Learning to lead in-between (old and new)
6. Inspiring others
Technician Objectives:
1. When facing the unknown, understand how to stay on course with the task or
question at hand.
2. Comprehend that complications arise from change.
3. Understand that change may/can provide an opportunity to enhance personal
growth.
4. Encourage a mutual understanding between parties when resistance to
change is encountered.
1
Thursday, March 24th (Continued)
Time
Total
Hours
10:00 – 11:00
1 hr
Speaker/Presentation Title
Christine Jolowsky, MS, R.Ph, FASHP – “Redefining the Practice Model:
Shaping the Future for Pharmacy Practice”
0134-0000-11-033-L04-P; 0134-0000-11-033-L04-T
Program Learning Objectives:
1. Discuss the goals of the ASHP/ASHP Foundation Pharmacy Practice
Model Initiative
2. Describe findings from the 2010 Pharmacy Practice Model Survey
3. Describe the results of recent systematic reviews of pharmacists'
impact on clinical, safety, humanistic and economic outcomes
4. Discuss pharmacist role in application of the recommendations from
the Pharmacy Practice Model Summit.
5. Describe changes in practice and new roles for pharmacy technicians.
6. Describe changes in education and training, including residencies that
will support changes in the practice model.
Technician Program Learning Objectives:
1. Discuss the goals of the ASHP/ASHP Foundation Pharmacy Practice
Model Initiative
2. Describe findings from the 2010 Pharmacy Practice Model Survey
3. Describe the results of recent systematic reviews of pharmacists'
impact on clinical, safety, humanistic and economic outcomes
4. Discuss the impact of the PPM changes to the technician role within the
practice of pharmacy
5. State changes in practice and the potential new and advanced roles for
technicians.
11:00 – 12:00
on
1 hr
Pamela Phelps,Pharm.D., FASHP – “Implementing Practice Model Change – Building
a Solid Foundation”
0134-0000-11-036-L04-P; 0134-0000-11-036-L04-T
Program Learning Objectives:
1. Identify the major elements of operational excellence in a Health-System
Pharmacy.
2. Describe the importance of employing process improvement techniques such
as Lean into your operations.
3. Discuss techniques that can be used to implement a successful practice model
change.
4. Identify outside resources that may be helpful when implementing a major
practice model change.
5. Describe the process of building support for a pharmacy department reform
from administrators, physicians and nurses.
6. Describe a 12 step process for implementing practice model change change.
Technician Program Learning Objectives:
1. Identify the major elements of operational excellence in a Health-System
Pharmacy
2. Describe the importance of employing process improvement techniques such
as Lean into your operations
3. Discuss techniques that can be used to implement a successful practice model
change
4. Identify outside resources that may be helpful when implementing a major
practice model change
2
Thursday, March 24th (Continued)
Time
11:00 – 12:00
Total
Hours
1 hr
Speaker/Presentation Title
Lisa Gersema, B.S., Pharm. D – “Clinical Practice”
0134-0000-11-035-L04-P; 0134-0000-11-034-L04-T
Program Learning Objectives:
1. Provide overview of successes and failures of previous practice model
summits to audience
2. Differentiate different types of practice models (distributive vs. clinical
vs. blended)
3. Define accountability as it relates to pharmacy practice
4. Identify minimal daily activities that should be completed by pharmacists
5. To describe critical elements important to assure a well-prepared technician
workforce
6. Define collaboration and its importance to an effective team-based approach to
medication management
Technician Program Learning Objectives:
1. Describe the role that technicians will play to allow the pharmacist to
focus on clinical activities during their practice
2. Differentiate the different pharmacist responsibilities in different types
of practice models (distributive vs clinical vs blended)
3. Describe what a pharmacist must to do to be “accountable” as it
relates to pharmacy practice
4. Describe the critical training and regulatory elements to ensure a wellprepared technician workforce
13:45 – 14:45
1 hr
Bruce Lohr, B.S., Pharm. D – “ICU Clinical Practice – Pro/Con: Precedex, Propofol, and
Benzos”
0134-0000-11-037-L01-P; 0134-0000-11-037-L01-T
Program Learning Objectives:
1. Contrast the advantages and disadvantages of the sedative agents available.
2. Discuss the results and limitations associated with the MENDS Trial.
3. State the benefits of using daily weaning of sedation therapy.
4. List the situations where sedation weaning is not appropriate
5. Contrast the commonly used sedation scales used in ICU clinical practice.
6. Describe Propofol Infusion Syndrome and the associated risk factors.
Technician Program Learning Objectives:
1. Describe the sedative mechanism of action for Propofol, Dexmedetomidine,
Lorazepam and Midazolam.
2. Contrast the duration of sedative action for Propofol, Dexmedetomidine,
Lorazepam and Midazolam.
3. State the usual dosage range for Propofol, Dexmedetomidine, Lorazepam and
Midazolam.
4. List the usual side effects associated with Propofol, Dexmedetomidine,
Lorazepam and Midazolam.
13:45 – 14:45
1 hr
Jillene Cernohous, Pharm. D – “Strategies for Managing Drug Shortages and Recalls”
0134-0000-11-038-L04-P; 0134-0000-11-038-L04-T
Program Learning Objectives:
1. Identify reasons for drug shortages and recalls.
2. Identify patient safety issues associated with drug shortages and recalls
3. Describe tips for managing shortages while balancing inventory and budgets
4. Outline strategies used to avoid medication errors and ensure patient safety.
5. List resources and contacts for identifying and managing drug shortages.
6. Describe how drug shortages and recalls affect pharmacy automation and HIS
software
3
Thursday, March 24th (Continued)
Time
Total
Hours
13:45 – 14:45
Speaker/Presentation Title
Jillene Cernohous (continued)
Technician Program Learning Objectives:
1. Discuss role of shortages and recalls in pharmacy automation.
2. Describe why drug shortages and recalls occur.
3. Outline resources for identify drug shortages.
4. Describe why drug shortages and recalls cause increase concern for patient
safety.
13:45 – 14:45
1 hr
Lance Swearingen, M.S., R.Ph. (PGY1) & Kevin Berg, R.Ph. (PGY2) – “How to Start
a Residency Program”
0134-0000-11-039-L04-P; 0134-0000-11-039-L04-T
Program Learning Objectives:
1. Explain the advantages of having a PGY2 residency program.
2. Compare the Residency Program Director’s (RPD) requirements for PGY1 RPD
vs PGY2 RPD
3. Compare the preceptor requirements for PGY1 preceptors and PGY2
preceptors.
4. Explain the benefits, to the organization and staff, in starting a Pharmacy
Practice Residency Program.
5. Evaluate if your hospital & preceptors meet ASHP Requirements to start a
Residency Program.
6. Develop a plan on initiating a Residency Program
Technician Program Learning Objectives:
1. Describe the value of a having a PGY2 residency program at your health
system.
2. Explain the difference between a PGY1 and PGY2 residency program.
3. Describe the role pharmacy technicians have in training a resident.
4. Explain the advantages of having a residency program.
15:15-16:15
1 hr
Christine Lee, Resident – United Hospital
Jocelyn Mohs, Resident – Fairview Maple Grove
Stephanie Root, Resident – Fairview Northland Hospital
“Resident Research Award Presentations”
0134-0000-11-049-L04-P; 0134-0000-11-049-L04-T
Program Learning Objectives:
1. Describe study methodology and/or interventions utilized to attain predefined
outcomes.
2. Interpret data or information collected to summarize project results.
3. Utilize study results to demonstrate the impact of residency research on
advancing pharmacy practice and attaining health-system and/or pharmacy
department goals.
4. Identify study limitations, steps for implementing research into practice and
implications for future research.
Technician Program Learning Objectives:
1. Describe the relationship between outcomes studied and influence on
technician work.
2. Summarize how the project results may impact pharmacy practice.
3. Demonstrate how residency research can advance pharmacy practice.
4. Identify future research opportunities related to advancing technician practice.
Total Hours:
8 hours (5 obtainable hours) – March 24, 2011
4
Friday, March 25th
Time
Total
Hours
9:15 -10:15
1 hr
Speaker/Presentation Title
Raquel Rodriguez, Ph.D. & Dawn Carlson, B.S., Pharm. D. – “Precepting Pearls”
0134-0000-11-040-L04-P; 0134-0000-11-040-L04-T
Program Learning Objectives:
1. Identify different types of pharmacy and patient care services in which
students can have a role
2. Identify strategies for incorporating experiential students into existing
pharmacy and patient care services.
3. Describe sample projects for students participating in the development or
implementation of a pharmacy service
4. Explain the importance of balancing student strengths and educational needs
with pharmacy practice needs.
5. Identify methods to overcome barriers to incorporating students into an
existing or new pharmacy service or operational structure.
6. Discuss the importance of involving the Office of Experiential Education
regarding student performance issues.
Technician Program Learning Objectives:
1. Identify different types of pharmacy and patient care services in which
students can have a role
2. Identify strategies for incorporating experiential students into existing
pharmacy and patient care services.
3. Describe sample projects for students participating in the development or
implementation of a pharmacy service
4. Explain the importance of balancing student strengths and educational needs
with pharmacy practice needs.
5. Identify methods to overcome barriers to incorporating students into an
existing or new pharmacy service or operational structure.
6. Discuss the importance of involving the Office of Experiential Education
regarding student performance issues.
9:15 – 10:15
1 hr
Dan Dauner, Pharm. D., MSPH, BCPS – “Vancomycin and Novel Antibiotics for the
Treatment of Gram-Positive Bacterial Infections”
0134-0000-11-041-L04-P; 0134-0000-11-041-L04-T
Program Learning Objectives:
1. Describe the epidemiology of vancomycin resistance among Staphylococcus
aureus isolates
2. Outline the recommended dosing of vancomycin
3. List the recommended targets for monitoring vancomycin therapy
4. Investigate the discordance between the E-test and automated testing
methods for vancomycin minimum inhibitory concentration (MIC) testing
5. Evaluate the importance of the vancomycin MIC for infections caused by
enterococci and coagulase-negative staphylococci
6. Analyze current literature regarding the treatment of MRSA pneumonia
7. List antibiotic options for the treatment of infections caused by Gram-positive
bacteria
Technician Program Learning Objectives:
1. Describe the epidemiology of vancomycin resistance among Staphylococcus
aureus
2. List examples of Gram-positive bacteria
3. List antibiotics used to treat MRSA
4. List antibiotic options for the treatment of infections caused by Gram-positive
bacteria
5
Time
Total
Hours
9:15 – 10:15
1 hr
Speaker/Presentation Title
Craig Else, Pharm.D. MHA – “Transitions of Care: How Can Pharmacy Evolve to Fit New
Models of Providing (and Paying for) Healthcare”
0134-0000-11-042-L04-P; 0134-0000-11-042-L04-T
Program Learning Objectives:
1. To understand the history of our current healthcare payment models and how
they affect the way we deliver care today
2. To evaluate different proposed payment reform models to control health care
costs
3. To describe the impact different payment models may have on the future of
pharmacy practice
4. To explain the similarities and differences among the various Care Transition
Models
5. To describe Fairview’s Care Transitions project and the active role of pharmacy
staff
6. To discuss possible roles for pharmacists and pharmacy technicians in new care
models that can lower total health care costs and improve patient satisfaction
and clinical quality
Technician Learning Objectives:
1. To understand the history of our current healthcare payment models and how
they affect the way we deliver care today
2. To describe the impact different payment models may have on the future of
pharmacy practice and how this may affect pharmacy technician roles
3. To describe Fairview’s Care Transitions project and the active role of pharmacy
technicians
4. To discuss possible roles for pharmacists and pharmacy technicians in new care
models that can lower total health care costs and improve patient satisfaction
and clinical quality
10:15 – 11:15
1 hr
Bradley Miller, MD, PhD – “Public Health Issues with Pediatric Obesity”
0134-0000-11-043-L01-P; 0134-0000-11-043-L01-T
Program Learning Objectives:
1. Report Prevalence of Childhood Obesity and describe changes in prevalence
over time.
2. Describe changes in prevalence of Childhood Obesity over time.
3. Describe medical therapies approved for treatment of obesity in children.
4. Describe complications of obesity that occur in childhood.
5. Describe therapeutic options for treatment of obesity complications in children.
6. Describe complications of childhood obesity that occur in adulthood.
Technician Learning Objectives:
1. Describe the prevalence of childhood obesity and how it’s changed over time.
2. Comprehend complications of childhood obesity that occur in adulthood.
3. Outline medical therapies approved for the treatment obesity in children.
4. Describe complications of obesity that occur in childhood.
6
Time
10:15 – 11:15
Total
Hours
1hr
Speaker/Presentation Title
Jim Mahowald, Pharm.D., BA, MA – “Role of Pharmacists After CPOE”
0134-0000-11-044-L05-P, 0134-0000-11-044-L05-T
Program Learning Objectives:
1. To describe the pharmacy practice model at St. Cloud Hospital
2. To review the St. Cloud Hospital timeline of Epic implementation
3. To review the St. Cloud Hospital timeline of CPOE implementation
4. To describe the pros and cons of CPOE implementation by patient care
area/physician specialties versus house wide
5. To detail the impact of CPOE on pharmacist workflow
6. To discuss future opportunities for pharmacists at St. Cloud Hospital
Technician Learning Objectives:
1. To describe the pharmacy practice model at St. Cloud Hospital
2. To review the St. Cloud Hospital timeline of Epic implementation
3. To review the St. Cloud Hospital timeline of CPOE implementation
4. To describe the pros and cons of CPOE implementation by patient care
area/physician specialties versus house wide
10:15 – 11:15
1 hr
Joseph Cappello, BA, MA – “Prevention of Drug Diversion – DEA Perspective”
0134-0000-11-046-L03-P; 0134-0000-11-046-LO3-T
Program Learning Objectives:
1. Identify the scope of pharmaceutical CS abuse
2. List the methods of pharmaceutical CS diversion
3. Describe the pharmaceutical CS demand
4. State the demographic of the pharmaceutical CS abuser
5. Explain Corresponding Liability
Technician Learning Objectives:
1. Identify methods for controlled substance abuse and diversion.
2. List features of the “typical” controlled substance abuser.
3. Describe the issues with corresponding liability.
11:15 – 12:15
1 hr
Richard Mullvain, R.Ph, BCPS (AQC) – “Cardiology Pharmacotherapy Update”
0134-0000-11-045-L01-P, 0134-0000-11-045-L01-T
Program Learning Objectives:
1. Examine part of the evolution of Clinical Pharmacy Practice (Hospital
Pharmacist and Retail)
2. Evaluate a professional journey to a new practice
3. Examine specific roles of a cardiovascular Pharmaceutical Care Practitioner
(MTM, STEMI Program Manager, Anticoagulation, System Support and
Education)
4. Describe important current Cardiovascular Drug Therapy Issues
5. Learn about new cardiac drug Issues, including a review of new anticoagulants
and antiplatelet medications)
6. Evaluate suggestions for future practice models and opportunities (System
Pharmacist, Specialization, Collaborative Teams)
Technician Learning Objectives:
1. Describe important current Cardiovascular Drug Therapy Issues
2. Learn about new cardiac drug Issues, including a review of new anticoagulants
and antiplatelet medications)
3. Examine part of the evolution of Clinical Pharmacy Practice
Hospital Pharmacist and Retail)
4. Learn about optimizing the drug therapy and systems of Heart Attack care for
Acute Myocardial Infarction, also known as STEMI
7
Time
Total
Hours
11:15 – 12:15
1 hr
Speaker/Presentation Title
Lee Mork, MBA MS, R.Ph – “Health System Electronic Prescription Implementation –
Lessons Learned”
0134-0000-11-047-L04-P, 0134-0000-11-047-L04-T
Program Learning Objectives:
1. To state the MN e-prescribing requirement
2. To express one of the benefits of e-prescribing to the patient
3. To describe one of the benefits of e-prescribing to the prescriber
4. To specify one of the keys to success
5. To explain the status of e-prescribing of controlled substances
6. To outline how e-prescribing can help determine the patient’s current
medication list for use during medication reconciliation
Technician Learning Objectives:
1. To state the MN e-prescribing requirement
2. To express one of the benefits of e-prescribing to the patient
3. To explain the status of e-prescribing of controlled substances
4. To specify one of the keys to success
11:15 – 12:15
1 hr
Mike Swanoski, Pharm.D., GGP, FASCP – “New Drugs of 2010 (and Early 2011)”
0134-0000-11-048-L04-P, 0134-0000-11-048-L04-T
Program Learning Objectives:
1. To list the names and doses of each new drug and identify the indication
2. To explain pharmacology/pharmacokinetics/pharmacodynamics of each new
drug
3. To state drug interactions
4. To describe adverse effects of each drug
5. To compare each new drug with current therapy and evaluate place in therapy
6. Know the cost of each new drug and compare to the cost of alternative therapy
choices
Technician Learning Objectives:
1. To list generic and brand-name of each new medication
2. To identify the indication of each new medication
3. To compare cost of each new medication with comparable therapies
4. To specify dosage form of each new medication
Total Hours:
9 hours (3 obtainable hours) – March 25, 2011
GRAND TOTAL:
17 Program Hours (8 obtainable hours) – March 24-25, 2011
8